Zions Bancorporation N.A. lowered its stake in shares of The Allstate Co. (NYSE:ALL – Free Report) by 8.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 918 shares of the insurance provider’s stock after selling 83 shares during the period. Zions Bancorporation N.A.’s holdings in Allstate were worth $174,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Northwest Investment Counselors LLC acquired a new position in Allstate in the 3rd quarter worth about $28,000. Catalyst Capital Advisors LLC acquired a new position in Allstate in the third quarter worth approximately $29,000. Versant Capital Management Inc lifted its stake in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 78 shares during the last quarter. Family Firm Inc. bought a new stake in Allstate in the second quarter worth approximately $38,000. Finally, MCF Advisors LLC increased its stake in shares of Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares during the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Allstate
In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of Allstate stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. The trade was a 50.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Toohey sold 16,682 shares of the business’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $180.17, for a total value of $3,005,595.94. Following the completion of the transaction, the executive vice president now directly owns 4,873 shares in the company, valued at approximately $877,968.41. This represents a 77.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 143,049 shares of company stock valued at $26,106,112 in the last ninety days. Insiders own 1.80% of the company’s stock.
Allstate Trading Up 0.6 %
Allstate (NYSE:ALL – Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.20 by $1.71. The firm had revenue of $16.63 billion during the quarter, compared to analyst estimates of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The company’s quarterly revenue was up 14.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.81 earnings per share. On average, analysts expect that The Allstate Co. will post 16.07 EPS for the current year.
Allstate Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, January 2nd. Investors of record on Friday, November 29th will be given a dividend of $0.92 per share. This represents a $3.68 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date of this dividend is Friday, November 29th. Allstate’s dividend payout ratio (DPR) is currently 23.83%.
Wall Street Analysts Forecast Growth
ALL has been the subject of a number of recent research reports. Wells Fargo & Company upped their price objective on shares of Allstate from $175.00 to $186.00 and gave the stock an “equal weight” rating in a report on Tuesday, November 5th. UBS Group raised their price objective on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Evercore ISI upped their target price on Allstate from $191.00 to $195.00 and gave the stock an “in-line” rating in a research report on Wednesday, October 9th. JPMorgan Chase & Co. lifted their price target on shares of Allstate from $205.00 to $207.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Finally, Bank of America raised their target price on shares of Allstate from $216.00 to $233.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $214.19.
View Our Latest Stock Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Featured Stories
- Five stocks we like better than Allstate
- What Are Growth Stocks and Investing in Them
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- ESG Stocks, What Investors Should Know
- Top-Performing Non-Leveraged ETFs This Year
- Buy P&G Now, Before It Sets A New All-Time High
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.